Coastal Bridge Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
23,959
-24,643
-51% -$1.34M 0.06% 226
2026
Q1
$3.05M Buy
48,602
+38,015
+359% +$3.04M 0.22% 105
2025
Q4
$1.01M Sell
10,587
-17
-0.2% -$1.67K 0.08% 211
2025
Q3
$1.04M Sell
10,604
-176
-2% -$18.2K 0.08% 206
2025
Q2
$1.16M Sell
10,780
-963
-8% -$97.4K 0.1% 192
2025
Q1
$1.18M Buy
+11,743
New +$1.18M 0.11% 180

Other funds holding BSX

Coastal Bridge Advisors's BSX Position: Q2 2026 in Review

Coastal Bridge Advisors reduced its Boston Scientific (BSX) stake by 51% in Q2 2026, selling an estimated $1.34M and leaving 23,959 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #226.

Coastal Bridge Advisors first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.05M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Coastal Bridge Advisors held 23,959 shares of Boston Scientific worth $1.02M as of Q2 2026.
  • Coastal Bridge Advisors sold 24,643 Boston Scientific shares in Q2 2026, an estimated $1.34M.
  • Boston Scientific made up 0.06% of Coastal Bridge Advisors's portfolio in Q2 2026, its #226 holding.
  • Coastal Bridge Advisors first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Coastal Bridge Advisors's Boston Scientific position peaked at $3.05M in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.